Kent is a Senior Vice President of Strategy, and leads Merkle’s Global Health Strategy practice. He has been consulting in the areas of pharmaceutical and animal health strategy for more than 20 years. He is published extensively in a variety of journals including, Research in Social and Administrative Pharmacy, Formulary, the Journal of Clinical Pharmacy and Therapeutics, and the Journal of Database Marketing. Kent is recognized as a subject matter expert in the area of factors influencing physician prescribing, is the author of several white papers, and most recently was the lead author for the chapter on Prescribing Behavior in Social and Behavioral Aspects of Pharmaceutical Care, 3rd Edition, published in 2016.
Kent has worked with a number of clients in the pharmaceutical, healthcare, and animal health vertical including Abbvie, AstraZeneca, BMS, Boehringer Ingelheim, Elanco, Gilead, GSK, Merck, Novartis, and Sanofi (Genzyme, Chattem and Merial), focusing on engagement and communication strategy in the US, Canada, Europe and Australasia. He has a PhD in Pharmaceutical Strategy and Policy from Dalhousie University in Halifax, NS, and holds the position of Assistant Professor, Clinical Pharmacy, at the James L Winkle College of Pharmacy, University of Cincinnati.